27 April 2017 – acquisition
The company has announced the acquisition of RJW & Partners Ltd. This is a business which provides consultancy services to the pharmaceutical and medical devices industries, working in pricing, market access and payer communications. Initial consideration is £1.75m for the business and £0.23m for cash balances held. £1.88m is payable in cash and £0.1m will be satisfied through the issue of 237,117 new ordinary shares. Further consideration of up to £4.25m is payable subject to financial performance between 2017 and 2020, of which 5% is payable in shares and 95% payable in cash. The shares remain a BUY.